✦ LIBER ✦

Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine

✍ Scribed by V. Ala-Hurula

Publisher: Springer
Year: 1982
Tongue: English
Weight: 635 KB
Volume: 21
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00542326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interindividual variability of oral suma

Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients

✍ Anna Ferrari; Diego Pinetti; Alfio Bertolini; Ciro Coccia; Emilio Sternieri 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 162 KB

Effects of steroid hormones and anti-mig

Effects of steroid hormones and anti-migraine drugs on serotonin transport in platelets of patients suffering from migraine and in those of healthy subjects

✍ T. G. Pukhal'skaya 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 441 KB

The correlation between historical, clin

The correlation between historical, clinical and urodynamic parameters in patients suffering from genuine stress urinary incontinence: Can a severity grading be considered?

✍ S. Meyer; P. de Grandi; G. Caccia 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 854 KB

Pharmacokinetics and clinical effects of

Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency

✍ R. A. Walstad; O. G. Nilsen; K. J. Berg 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 722 KB

The correlation between patient characte

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials

✍ Kevin P. Weinfurt; Liana D. Castel; Yun Li; Daniel P. Sulmasy; Andrew M. Balshem 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract ## BACKGROUND Patients in Phase I clinical trials sometimes report high expectations regarding the benefit of treatment. The authors examined a range of patient characteristics to determine which factors were associated with greater expectations of benefit from Phase I trials. ## METH

D-penicillamine in patients with rheumat

D-penicillamine in patients with rheumatoid arthritis serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects

✍ A. O. Muijsers; R. J. Van De Stadt; A. M. A. Henrichs; H. J. W. Ament; J. K. Van 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

After administration of D-penicillamine to patients with rheumatoid arthritis, measurements of serum level and urinary excretion showed half-life times of 1.6 hours in the rapid phase and 4-6 days in the slow phase. The latter evidence suggests that tissue pooling occurs. With a dosage of 750 mglday